+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative



Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative



Archives of Internal Medicine 166(3): 357-365



Background: In recent randomized trials, conjugated equine estrogens (CEE) with continuous medroxyprogesterone acetate provided no protection against coronary heart disease in postmenopausal women and may have increased cardiac risk.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 011894646

Download citation: RISBibTeXText

PMID: 16476878

DOI: 10.1001/archinte.166.3.357


Related references

Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. American Heart Journal 152(1): 170-176, 2006

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291(24): 2959-2968, 2004

Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291(24): 2947-2958, 2004

Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. American Journal of Epidemiology 167(12): 1407-1415, 2008

Conjugated equine estrogens and colorectal cancer incidence and survival: the Women's Health Initiative randomized clinical trial. Cancer Epidemiology Biomarkers and Prevention 17(10): 2609-2618, 2008

Re: "Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study". American Journal of Epidemiology 168(10): 1213; Author Reply 1213-4, 2008

Effects of oral conjugated equine estrogens with or without medroxyprogesterone acetate on incident hypertension in the Women's Health Initiative hormone therapy trials. Menopause 25(7): 753-761, 2018

Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Medicine 1(4): 47, 2009

Letter by Lehmann regarding articles "Electrocardiographic abnormalities that predict coronary heart disease events and mortality in postmenopausal women: the Women's Health Initiative" and "Electrocardiographic predictors of incident congestive heart failure and all-cause mortality in postmenopausal women: the Women's Health Initiative". Circulation 113(23): E854-E854, 2006

Coronary heart disease events in the Women's Health Initiative hormone trials: effect modification by metabolic syndrome: a nested case-control study within the Women's Health Initiative randomized clinical trials. Menopause 20(3): 254-260, 2013

Conjugated equine estrogens and breast cancer risk in the womens health initiative clinical trial and observational study. American Journal of Epidemiology 167(12): 1407-1415, 2008

Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial. Archives of Internal Medicine 165(17): 1976-1986, 2005

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291(14): 1701-1712, 2004

Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 113(20): 2425-2434, 2006

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial. Journal of Clinical Oncology 27(36): 6135-6143, 2009